Baxter Healthcare Corporation vs GlaxoSmithKline Consumer Healthcare Holdings LLC: FDA Enforcement Comparison

Baxter Healthcare Corporation has been the subject of 208 FDA enforcement/approval records tracked by Argus HQ, compared to 7 for GlaxoSmithKline Consumer Healthcare Holdings LLC.

Baxter Healthcare Corporation: 0 warning letters, 208 recalls, 0 approval records, 0 Form 483s.

GlaxoSmithKline Consumer Healthcare Holdings LLC: 0 warning letters, 7 recalls, 0 approval records, 0 Form 483s.

Side by side

Baxter Healthcare Corporation — Warning letters0

GlaxoSmithKline Consumer Healthcare Holdings LLC — Warning letters0

Baxter Healthcare Corporation — Recalls208

GlaxoSmithKline Consumer Healthcare Holdings LLC — Recalls7

Baxter Healthcare Corporation — Approval records0

GlaxoSmithKline Consumer Healthcare Holdings LLC — Approval records0

Baxter Healthcare Corporation — Form 483s0

GlaxoSmithKline Consumer Healthcare Holdings LLC — Form 483s0

Timeline

Baxter Healthcare Corporation

Most recent FDA action: July 8, 2026

Full history →

GlaxoSmithKline Consumer Healthcare Holdings LLC

Most recent FDA action: November 8, 2023

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Baxter Healthcare Corporation vs GlaxoSmithKline  Consumer Healthcare Holdings LLC: FDA Enforcement Comparison." Argus HQ, accessed July 17, 2026. https://argushq.ai/compare/baxter-healthcare-corporation-vs-glaxosmithkline-consumer-healthcare-holdings-llc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗